Pasithea Therapeutics Corp. (KTTA) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Miami Beach, FL, アメリカ. 現CEOは Tiago Reis Marques.
KTTA を有する IPO日 2021-09-15, 4 名の正社員, に上場 NASDAQ Capital Marke, 時価総額 $5.37M.
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
